Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants.

Frontiers in Immunology
Ying LiCherie L Stabler

Abstract

Allogeneic islet transplantation is a promising cell-based therapy for Type 1 Diabetes (T1D). The long-term efficacy of this approach, however, is impaired by allorejection. Current clinical practice relies on long-term systemic immunosuppression, leading to severe adverse events. To avoid these detrimental effects, poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) were engineered for the localized and controlled release of immunomodulatory TGF-β1. The in vitro co-incubation of TGF-β1 releasing PLGA MPs with naïve CD4+ T cells resulted in the efficient generation of both polyclonal and antigen-specific induced regulatory T cells (iTregs) with robust immunosuppressive function. The co-transplantation of TGF-β1 releasing PLGA MPs and Balb/c mouse islets within the extrahepatic epididymal fat pad (EFP) of diabetic C57BL/6J mice resulted in the prompt engraftment of the allogenic implants, supporting the compatibility of PLGA MPs and local TGF-β1 release. The presence of the TGF-β1-PLGA MPs, however, did not confer significant graft protection when compared to untreated controls, despite measurement of preserved insulin expression, reduced intra-islet CD3+ cells invasion, and elevated CD3+Foxp3+ T cells at the peri-transpla...Continue Reading

References

Mar 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·M R NicollsR G Gill
Mar 29, 2000·Journal of Biomedical Materials Research·L LuA G Mikos
May 4, 2000·The New England Journal of Medicine·G C BlobeH F Lodish
Jun 6, 2000·Advanced Drug Delivery Reviews·M S Shive, J M Anderson
Dec 31, 2002·Pharmaceutical Development and Technology·Ge JiangPatrick P DeLuca
Mar 17, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Sulaiman A NanjiA M James Shapiro
Mar 30, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yisong Y Wan, Richard A Flavell
Nov 25, 2005·Diabetes·Béatrice FaideauChristian Boitard
Sep 29, 2006·The New England Journal of Medicine·UNKNOWN Worcester Human Islet Transplantation GroupA A Rossini
Mar 3, 2007·Cardiovascular Research·Paul L HermonatJawahar L Mehta
Mar 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Allison L BayerThomas R Malek
Jul 20, 2007·Biochemical Society Transactions·J GauldieM Kolb
Aug 8, 2008·Current Opinion in Organ Transplantation·Behdad AfzaliRobert I Lechler
Aug 12, 2008·Cell·Ming O Li, Richard A Flavell
Aug 20, 2008·The Journal of Experimental Medicine·John AnderssonEthan M Shevach
Nov 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sayuri YamazakiRalph M Steinman
Dec 26, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sunil K ChauhanReza Dana
Jun 23, 2009·Biochimica Et Biophysica Acta·Dirk PohlersGunter Wolf
Aug 7, 2009·European Journal of Immunology·Ben M IlligensGilles Benichou
Jun 5, 2010·Circulation Research·Marcin DobaczewskiNikolaos G Frangogiannis
Jul 10, 2010·Current Opinion in Organ Transplantation·Niloufar SafiniaGiovanna Lombardi
May 14, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K L HippenB R Blazar
Jan 31, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Siddharth JhunjhunwalaSteven R Little
Apr 25, 2012·Advanced Materials·Stephen C Balmert, Steven R Little
Jul 17, 2012·Cell Transplantation·Morihito TakitaMarlon F Levy
Oct 4, 2012·Cell Transplantation·Eileen PedrazaCherie L Stabler
Jan 1, 2012·The Review of Diabetic Studies : RDS·Valentina Di CaroMassimo Trucco
Aug 7, 2013·Current Diabetes Reports·Boris Gala-LopezA M James Shapiro
Nov 5, 2013·Cold Spring Harbor Perspectives in Medicine·Aurélie MoreauMaria-Cristina Cuturi
Nov 5, 2013·Endokrynologia Polska·Dariusz KajdaniukBeata Kos-Kudła
Dec 21, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K LeeQ Tang
Apr 24, 2014·International Journal of Clinical Pharmacology and Therapeutics·Chun XuZhong-Yang Shen
Apr 30, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Jamal S LewisBenjamin G Keselowsky
Jul 16, 2014·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Anthony BruniAm James Shapiro
Apr 7, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jamal S LewisBenjamin G Keselowsky

❮ Previous
Next ❯

Software Mentioned

ImageJ
Prism GraphPad
FCS Express
GraphPad Prism

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.